Acknowledgement for APICES collaboration in INMUNOSUN study published in «ESMO Open»

APICES, monitoring, Phase II, Publications, renal cell carcinomaDeja un comentario

We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy”, a study in which APICES has participated in study design, setup,…

Acknowledgment for APICES collaboration in BIBABRAX Study published in Cancer Chemotherapy and Pharmacology

AEMPS, APICES, ASCO, Clinical Trials, Deterioration-Free Survival, Gemcitabine, Nab-Paclitaxel, Phase II, Quality, Quality of LifeDeja un comentario

Once again, we are privileged to share the acknowledgment that APICES has received in the recent publication titled «Phase II clinical trial of nab‑paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study»  published in Cancer Chemotherapy and Pharmacology and related with one study conducted by APICES, which has…